Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 204516 / DOSAGE - CAPSULE;ORAL - EQ 7.5MG BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| PAROXETINE MESYLATE(UNII: M711N184JE) (PAROXETINE - UNII:41VRH5220H) | PAROXETINE | 7.5mg |
Inactive Ingredients
| Ingredient Name | Solco Healthcare LLC | Noven Therapeutics, LLC | Sebela Pharmaceuticals Inc. |
|---|---|---|---|
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE(L11K75P92J) | |||
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS(L11K75P92J) | |||
| FD&C RED NO. 3(PN2ZH5LOQY) | |||
| FD&C RED NO. 40(WZB9127XOA) | |||
| FD&C YELLOW NO. 6(H77VEI93A8) | |||
| FERROSOFERRIC OXIDE(XM0M87F357) | |||
| GELATIN(2G86QN327L) | |||
| GELATIN, UNSPECIFIED(2G86QN327L) | |||
| MAGNESIUM STEARATE(70097M6I30) | |||
| POTASSIUM HYDROXIDE(WZH3C48M4T) | |||
| PROPYLENE GLYCOL(6DC9Q167V3) | |||
| SHELLAC(46N107B71O) | |||
| SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2) | |||
| TITANIUM DIOXIDE(15FIX9V2JP) |
